scispace - formally typeset
H

Helge B. Bode

Researcher at Goethe University Frankfurt

Publications -  273
Citations -  11418

Helge B. Bode is an academic researcher from Goethe University Frankfurt. The author has contributed to research in topics: Photorhabdus & Xenorhabdus. The author has an hindex of 50, co-authored 254 publications receiving 9066 citations. Previous affiliations of Helge B. Bode include Saarland University & University of Bonn.

Papers
More filters
Journal ArticleDOI

Big effects from small changes: Possible ways to explore nature's chemical diversity

TL;DR: The systematic alteration of easily accessible cultivation parameters in order to increase the number of secondary metabolites available from one microbial source is investigated and the OSMAC approach seems to be a useful tool to detect those metabolites that are postulated to be the final products of an amazing number of typical secondary metabolites gene clusters identified in several microorganisms.
Journal ArticleDOI

Minimum Information about a Biosynthetic Gene cluster.

Marnix H. Medema, +164 more
TL;DR: This work proposes the Minimum Information about a Biosynthetic Gene cluster (MIBiG) data standard, to facilitate consistent and systematic deposition and retrieval of data on biosynthetic gene clusters.
Journal ArticleDOI

Complete genome sequence of the myxobacterium Sorangium cellulosum

TL;DR: The complete genome sequence of the model Sorangium strain S. cellulosum So ce56 is reported, which produces several natural products and has morphological and physiological properties typical of the genus, and the circular genome is the largest bacterial genome sequenced to date.
Journal ArticleDOI

Entomopathogenic bacteria as a source of secondary metabolites.

TL;DR: This review focuses on recent advances in the understanding of secondary metabolism of Bacillus thuringiensis, Pseudomonas entomophila, and Xenorhabdus and PhotorhabDus bacteria all of which are entomopathogenic.
Journal ArticleDOI

Towards the sustainable discovery and development of new antibiotics

TL;DR: In this paper, the authors present a strategic blueprint to substantially improve our ability to discover and develop new antibiotics, and propose both short-term and long-term solutions to overcome the most urgent limitations in the various sectors of research and funding.